Prevention of Invasive Aspergillus Fungal Infections with the Suspension and Delayed-Release Tablet Formulations of Posaconazole in Patients with Haematologic Malignancies
Sign Up to like & getrecommendations! Published in 2018 at "Scientific Reports"
DOI: 10.1038/s41598-018-20136-3
Abstract: Posaconazole is a triazole antifungal used to prevent invasive fungal infections (IFIs) in patients receiving chemotherapy or haemotopoietic stem cell transplantation. Due to highly variable bioavailability of the oral suspension formulation, a delayed-release tablet was… read more here.
Keywords: fungal infections; suspension; patients haematologic; delayed release ... See more keywords
Timing of referral to outpatient palliative care for patients with haematologic malignancies
Sign Up to like & getrecommendations! Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18365
Abstract: Outpatient palliative‐care facilitates timely supportive‐care access; however, there is a paucity of studies on the timing of referral in the outpatient setting for patients with haematologic malignancy. We examined the trend in timing of outpatient… read more here.
Keywords: timing referral; outpatient palliative; palliative care; care ... See more keywords
Antifungal prophylaxis with posaconazole tablet and oral suspension in patients with haematologic malignancy: Therapeutic drug monitoring, efficacy and risk factors for the suboptimal level
Sign Up to like & getrecommendations! Published in 2019 at "Mycoses"
DOI: 10.1111/myc.13020
Abstract: Posaconazole is used to prevent invasive fungal infections (IFIs) in patients with haematologic malignancy. In this study, we compared plasma posaconazole concentrations (PPCs) and the incidence of breakthrough IFIs between patients with haematologic malignancy receiving… read more here.
Keywords: patients haematologic; haematologic malignancy; oral suspension; antifungal prophylaxis ... See more keywords
Breakthrough COVID-19 in Vaccinated Patients with Haematologic Malignancies—The First Single-Centre Experience from the Czech Republic
Sign Up to like & getrecommendations! Published in 2022 at "Life"
DOI: 10.3390/life12081184
Abstract: Vaccination is an important tool in the fight against the COVID-19 pandemic in patients with haematologic malignancies. The paper provides an analysis of the course of breakthrough SARS-CoV-2 infection in a group of vaccinated patients… read more here.
Keywords: covid vaccinated; vaccinated patients; covid; breakthrough covid ... See more keywords